Corton Capital’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
Corton Capital's CGEM Position: Q3 2025 in Review
Corton Capital increased its Cullinan Therapeutics (CGEM) stake by 25% in Q3 2025, buying an estimated $39.6K and bringing the position to 27,117 shares worth $161K. The position accounts for 0.4% of the portfolio, ranked #138.
Corton Capital first reported a position in CGEM in Q4 2024 and has held it in 4 quarters since. The position peaked at $163K in Q2 2025. 145 funds tracked by Wall St. Rank hold CGEM as of Q3 2025.
- Corton Capital held 27,117 shares of Cullinan Therapeutics worth $161K as of Q3 2025.
- Corton Capital bought 5,405 Cullinan Therapeutics shares in Q3 2025, an estimated $39.6K.
- Cullinan Therapeutics made up 0.4% of Corton Capital's portfolio in Q3 2025, its #138 holding.
- Corton Capital first reported a position in Cullinan Therapeutics in Q4 2024 and has held it in 4 quarters since.
- Corton Capital's Cullinan Therapeutics position peaked at $163K in Q2 2025.
- 145 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2025.
Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.